Table 3.
Glycans | CRC | UC | CD | SLE | RA | CKD | PD | HT | T2D | O | DL* | IS |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GP1 | ↑ | – | – | ↑ | ↑ | – | – | – | – | – | – | ↑ |
GP2 | ↑ | – | – | ↑ | ↑ | ↑ | – | – | – | – | ↑ | – |
GP3 | ↑ | – | – | – | – | – | – | – | – | – | – | – |
GP4 | ↑ | ↑ | ↑ | ↑ | – | – | – | ↑ | – | – | ↑ | – |
GP5 | ↑ | – | – | ↑ | – | – | ↓ | – | – | – | ↑ | ↓ |
GP6 | ↑ | ↑ | ↑ | ↑ | – | ↑ | – | ↑ | ↑ | – | ↑ | – |
GP7 | – | – | – | ↑ | – | – | – | – | – | – | – | – |
GP8 | ↓ | – | – | ↓ | – | – | ↑ | – | ↓ | – | – | ↑ |
GP9 | ↓ | ↓ | ↓ | ↓ | – | – | – | – | ↓ | – | – | – |
GP10 | ↓ | – | – | ↑ | – | – | – | – | ↑ | – | – | – |
GP11 | ↓ | – | – | – | – | – | – | – | ↑ | – | ↑ | – |
GP12 | ↓ | – | – | ↑ | – | – | – | ↓ | – | – | – | – |
GP13 | ↓ | – | – | – | – | – | – | ↓ | – | – | – | ↓ |
GP14 | ↓ | ↓ | ↓ | ↓ | – | ↓ | ↑ | ↓ | – | ↓ | ↓ | ↓ |
GP15 | ↓ | – | – | – | – | – | – | ↓ | – | – | – | ↓ |
GP16 | ↑ | – | – | ↓ | – | – | – | – | – | – | – | – |
GP17 | – | – | – | ↑ | – | – | ↓ | – | – | – | – | ↓ |
GP18 | ↓ | ↓ | ↓ | ↓ | – | ↓ | – | ↓ | – | ↓ | ↓ | ↓ |
GP19 | ↓ | – | ↓ | ↑ | – | – | – | – | – | – | – | – |
GP20 | – | – | – | – | – | – | ↓ | – | – | – | ↑ | – |
GP21 | – | – | – | – | – | – | ↓ | – | – | – | ↑ | ↓ |
GP22 | ↓ | – | – | ↑ | ↓ | – | ↓ | – | – | – | – | – |
GP23 | – | – | – | ↓ | – | – | – | – | – | – | – | ↓ |
GP24 | – | – | – | ↑ | ↑ | – | – | – | – | – | – | – |
Galactosylation | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ↓ |
Sialylation | ↓ | – | ↓ | ↓ | – | ↓ | ↓ | ↓ | ↓ | – | ↓ | ↓ |
Fucosylation | ↑ | – | – | ↓ | ↑ | – | – | ↓ | ↓ | – | – | – |
Bisecting GlcNAc | ↓ | – | ↑ | ↑ | – | ↑ | – | ↑ | ↑ | – | ↑ | ↑ |
↑ high level of glycans can increase the risk of disease. ↓ low level of glycans can increase the risk of disease. CRC colorectal cancer, UC ulcerative colitis, CD Crohn’s disease, SLE systemic lupus erythematosus, RA rheumatoid arthritis, CKD chronic kidney disease, PD Parkinson’s disease, HT hypertension, T2D type 2 diabetes, O obesity, DL dyslipidemia, IS ischemic stroke
*Unpublished paper